List view / Grid view
Researchers have discovered a protein, Ait1, that is responsible for controlling cell growth in yeasts. Since humans and yeasts have remarkably similar cellular mechanisms, teasing out the differences presents drug developers with new target.
A nanotherapeutic delivery system displayed high efficacy against metastatic tumours in mice, potentially improving chemotherapy treatments.
A new study has shown that the mutated FBXO31 and RHOB genes can each alone cause cerebral palsy, offering potential drug targets.
A new study by the University of Arizona (UA) suggests that revealing all the steps required to activate an enzyme called a protein kinase may help identify new ways to target cancer.
Genistein, a component of soy foods, may suppress the development of breast cancer by protecting BRCA1...
11 May 2016 | By Victoria White, Digital Content Producer
Scientists have proven that a model of the human gut - HuMiX - is representative of the actual conditions and processes that occur within our intestines...
The success story of Mapp Pharmaceuticals’ experimental drug, ZMapp, during last year’s Ebola outbreak highlights the potential of plant-made monoclonal antibodies (mAbs) as life-saving treatments.
11 November 2015 | By Victoria White
Scientists found that patients who began taking levodopa before they developed macular degeneration were diagnosed with the eye disease eight years later than those who had never taken the treatment...
